Clinical Trial Update: Glioblastoma Targeted Treatment Option Maximization by WGS [NA]

View source ↗

Summary

A clinical trial at UMC Utrecht is exploring whole-genome sequencing–guided, targeted treatment options for glioblastoma and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Snippet

Sponsor: UMC Utrecht | Conditions: Glioblastoma | NA | Status: RECRUITING